Quality of life and its associated factors among psoriasis patients in al-thawra hospital, sana’a city, yemen: a cross-sectional study
DOI:
https://doi.org/10.65693/irss.2024.v5i1.426Keywords:
psoriasis quality of life, Yemen.Abstract
Background: This study aimed to describe the health- related quality of life and its associated factors among psoriasis patients in dermatology outpatient clinic in AL-Thawra hospital, Sana’a City, Yemen
Methods: A descriptive cross-sectional study was conducted among 56 patients with psoriasis at the dermatology clinic in AL-Thawra hospital, Sana’a City, Yemen, via a self-administered questionnaire that included sociodemographic and clinical manifestations variables, the dermatology life quality index. Data obtained were analyzed using SPSS Software. Descriptive statistics were performed to describe the socio-demographic, risk factors for quality-of-life variables. Data described by frequencies, percentages, means & SD. Chi square test was used to test differences the risk factors for quality-of-life variable in relation with socio-demographic characteristics. Test considered to be significant p. value < 0.05.
Results: The results of the study showed that the quality of life was (42.9%) of psoriasis patients were affected to a very large extent, (1.8%) were affected very significantly, the quality of life of (26.8%) to a medium degree, (21.4%) quality of life was affected significantly and non-significantly, (7.1%) of patients with psoriasis were not affected. The results related to the demographic factors of psoriasis patients showed that most were females, average age 38.6 years, (83.9%) lived in urban, (42.9%) had a diploma, one third of them had a low educational level, two thirds of psoriasis patients were married, (73.2%) have not health insurance. average income (43,087) Yemeni riyals. The results related to Clinical factors of psoriasis patients, it found that the average weight was (62) km, the average height (157) cm, (83.9%) have age onset of less than 40 y, (46.4%) had a duration of injury less than 10 y, (44.6%) the sever moderate, the guttate psoriasis was prominent symptom, the affected skin site was the external skin (60.7%), 55% their had a skin surface lesion of less than 30%. Three quarters of the respondents do not smoke, (98.2%) non-alcoholic, (89.3%) non exercise. The results of the study showed that There was no relationship between Dermatology Life Quality Index and demographic variables, except for the family income level variable, and no relationship between Dermatology Life Quality Index and clinically relevant factors, except for the height variable, as well as no relationship between Dermatology Life Quality Index and lifestyle factors.
Conclusion: The results of the study showed that the quality of life for 44.7% out of 56 patients with psoriasis was affected to a very large extent, that psoriasis is a common disease that affects all groups. The level of clinical severity of psoriasis was moderate. Guttate psoriasis was a prominent symptom. The external skin was the most affected.The level of family income and the length of patients are important indicators in affecting the quality of life in patients with psoriasis, and there is no relationship between Dermatology Life Quality Index and lifestyle factors.
References
Agency, E. M. (2005). Committee for Medicinal Products for Human Use: Guideline on similar biological medicinal products: EMEA London.
Ahmad Fuat, M. S., Mat Yudin, Z., Muhammad, J., & Mohd Zin, F. (2022). Quality of Life and Its Associated Factors among Patients with Psoriasis in a Semi-Urban Northeast Malaysia. International Journal of Environmental Research and Public Health, 19(18), 11578.
Alexis, A. F., & Blackcloud, P. (2014). Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances. The Journal of clinical and aesthetic dermatology, 7(11), 16.
Ali, F., Cueva, A., Vyas, J., Atwan, A., Salek, M., Finlay, A., & Piguet, V. (2017). A systematic review of the use of quality‐of‐life instruments in randomized controlled trials for psoriasis. British Journal of Dermatology, 176(3), 577-593.
Armstrong, A., Harskamp, C., Dhillon, J., & Armstrong, E. (2014). Psoriasis and smoking: a systematic review and meta‐analysis. British Journal of Dermatology, 170(2), 304-314.
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2013). Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA dermatology, 149(1), 84-91.
Both, H., Essink-Bot, M.-L., Busschbach, J., & Nijsten, T. (2007). Critical review of generic and dermatology-specific health-related quality of life instruments. Journal of Investigative Dermatology, 127(12), 2726-2739.
Brenaut, E., Horreau, C., Pouplard, C., Barnetche, T., Paul, C., Richard, M. A., . . . Aubin, F. (2013). Alcohol consumption and psoriasis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology, 27, 30-35.
Brezinski, E. A., Dhillon, J. S., & Armstrong, A. W. (2015). Economic burden of psoriasis in the United States: a systematic review. JAMA dermatology, 151(6), 651-658.
Broadbent, E., Petrie, K. J., Main, J., & Weinman, J. (2006). The brief illness perception questionnaire. Journal of psychosomatic research, 60(6), 631-637.
Broadbent, E., Wilkes, C., Koschwanez, H., Weinman, J., Norton, S., & Petrie, K. J. (2015). A systematic review and meta-analysis of the Brief Illness Perception Questionnaire. Psychology & health, 30(11), 1361-1385.
Cappelleri, J., Bushmakin, A., Harness, J., & Mamolo, C. (2013). Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity. Quality of Life Research, 22, 2489-2499.
CDC. (2020). Psoriasis. Retrieved from https://www.cdc.gov/psoriasis/index.htm
Chen, C.-Y. (2016). Quality of Life and its associated factors for psoriasis patients in China: A cross-sectional study from hospital-based data.
Coates, L. C., & Helliwell, P. S. (2017). Psoriatic arthritis: state of the art review. Clinical Medicine, 17(1), 65.
Danielsen, K., Olsen, A., Wilsgaard, T., & Furberg, A. S. (2013). Is the prevalence of psoriasis increasing? A 30‐year follow‐up of a population‐based cohort. British Journal of Dermatology, 168(6), 1303-1310.
Ding, X., Wang, T., Shen, Y., Wang, X., Zhou, C., Tian, S., . . . Xue, S. (2012). Prevalence of psoriasis in China: a population-based study in six cities. European Journal of Dermatology, 22(5), 663-667.
Dogra, S., & Kamat, D. (2019). Drug-induced psoriasis. Indian Journal of Rheumatology, 14(Suppl 1), S37-S43.
Duan, X., Liu, J., Mu, Y., Liu, T., Chen, Y., Yu, R., . . . Wu, T. (2020). A systematic review and meta-analysis of the association between psoriasis and hypertension with adjustment for covariates. Medicine, 99(9).
Edson-Heredia, E., Zhu, B., Guo, J., Maeda-Chubachi, T., & Lebwohl, M. (2015). Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveys. Cutis, 95(3), 173-178.
Ferreira, B. I. R. C., Abreu, J. L. P. D. C., Dos Reis, J. P. G., & Figueiredo, A. M. D. C. (2016). Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. The Journal of clinical and aesthetic dermatology, 9(6), 36.
Fleming, P., Bai, J., Pratt, M., Sibbald, C., Lynde, C., & Gulliver, W. (2017). The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials. Journal of the European Academy of Dermatology and Venereology, 31(5), 798-807.
Foundation, N. P. (2022). Psoriasis Statistics: The Impacts of Psoriasis. Retrieved from https://www.psoriasis.org/psoriasis-statistics/#:~:text=The%20Impacts%20of%20Psoriasis,there%20is%20no%20cure%2C%20yet.&text=125%20million%20people%20worldwide%E2%80%942,the%20World%20Psoriasis%20Day%20consortium.
García-Sánchez, L., Montiel-Jarquín, Á. J., Vázquez-Cruz, E., May-Salazar, A., Gutiérrez-Gabriel, I., & Loría-Castellanos, J. (2017). Quality of life in patients with psoriasis. Gaceta medica de Mexico, 153(2), 185-189.
GBoDC, N. (2012). Global burden of disease study 2010 (GBD 2010) results by cause 1990-2010. Seattle, United States: Institute for Health Metrics and Evaluation (IHME).
Gottlieb, A. B., & Dann, F. (2009). Comorbidities in patients with psoriasis. The American journal of medicine, 122(12), 1150. e1151-1150. e1159.
Group, W. (1995). The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Social science & medicine, 41(10), 1403-1409.
Gupta, M. A., Schork, N. J., Gupta, A. K., & Ellis, C. N. (1993). Alcohol intake and treatment responsiveness of psoriasis: a prospective study. Journal of the American Academy of Dermatology, 28(5), 730-732.
Häbel, H., Wettermark, B., Hägg, D., Villacorta, R., Wennerström, E. C. M., & Linder, M. (2021). Societal impact for patients with psoriasis: A nationwide Swedish register study. JAAD international, 3, 63-75.
Hagger, M. S., & Orbell, S. (2003). A meta-analytic review of the common-sense model of illness representations. Psychology and health, 18(2), 141-184.
Harden, J. L., Krueger, J. G., & Bowcock, A. M. (2015). The immunogenetics of psoriasis: a comprehensive review. Journal of autoimmunity, 64, 66-73.
He, Z., Lu, C., Basra, M., Ou, A., Yan, Y., & Li, L. (2013). Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis. Journal of the European Academy of Dermatology and Venereology, 27(1), 109-115.
Je, G. (2007). elder Jt Psoriasis: epidemiology. clinics in Dermatology.
Joseph, D. M., Binitha, M. P., Jithu, V., Vasudevan, B., & Jishna, P. (2021). Determinants of quality of life in patients with psoriasis attending the dermatology outpatient clinic in a tertiary care center: A cross-sectional study. Journal of Skin and Sexually Transmitted Diseases, 3(2), 156-161.
Kaaz, K., Szepietowski, J., & Matusiak, Ł. (2019). Sleep quality among adult patients with chronic dermatoses. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 36(6), 659-666.
Koo, J., & Arain, S. (1998). Traditional Chinese medicine for the treatment of dermatologic disorders. Archives of Dermatology, 134(11), 1388-1393.
Kumsa, S. M., Tadesse, T. A., & Woldu, M. A. (2021). Management practice, quality of life and associated factors in psoriasis patients attending a dermatological center in Ethiopia. PLoS One, 16(11), e0260243.
Lara, T., Federica, R., Leonardo, P., Gionata, B., & Francesca, P. (2012). Severity of psoriasis and body mass index: the cut off are overweight patients rather Than obese ones. J Clin Exp Dermatol Res, 3(165), 1-5.
Lee, E. B., Wu, K. K., Lee, M. P., Bhutani, T., & Wu, J. J. (2018). Psoriasis risk factors and triggers. Cutis, 102(5S), 18-20.
Liang, S. E., Cohen, J. M., & Ho, R. S. (2019). Psoriasis and suicidality: A review of the literature. Dermatologic therapy, 32(1), e12771.
Meier, M., & Sheth, P. B. (2009). Clinical spectrum and severity of psoriasis. Management of psoriasis, 38, 1-20.
Meneguin, S., de Godoy, N. A., Pollo, C. F., Miot, H. A., & de Oliveira, C. (2020). Quality of life of patients living with psoriasis: a qualitative study. BMC dermatology, 20(1), 1-6.
Naldi, L., Conti, A., Cazzaniga, S., Patrizi, A., Pazzaglia, M., Lanzoni, A., . . . Group, P. E. R. S. (2014). Diet and physical exercise in psoriasis: a randomized controlled trial. British Journal of Dermatology, 170(3), 634-642.
Norris, D., Photiou, L., Tacey, M., Dolianitis, C., Varigos, G., Foley, P., & Baker, C. (2017). Biologics and dermatology life quality index (DLQI) in the Australasian psoriasis population. Journal of Dermatological Treatment, 28(8), 731-736.
Obradors, M., Blanch, C., Comellas, M., Figueras, M., & Lizan, L. (2016a). Health-related quality of life in patients with psoriasis: a systematic review of the European literature. Quality of Life Research, 25(11), 2739-2754.
Obradors, M., Blanch, C., Comellas, M., Figueras, M., & Lizan, L. (2016b). Health-related quality of life in patients with psoriasis: a systematic review of the European literature. Quality of Life Research, 25, 2739-2754.
Ockenfels, H., Keim‐Maas, C., Funk, R., Nussbaum, G., & Goos, M. (1996). Ethanol enhances the IFN‐γ, TGF‐α and IL‐6 secretion in psoriatic co‐cultures. British Journal of Dermatology, 135(5), 746-751.
Organization, W. H. (2016). World Health Organization global report on psoriasis. Geneva: World Health Association.
Parisi, R., Iskandar, I. Y., Kontopantelis, E., Augustin, M., Griffiths, C. E., & Ashcroft, D. M. (2020). National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. Bmj, 369.
Parisi, R., Symmons, D. P., Griffiths, C. E., & Ashcroft, D. M. (2013). Global epidemiology of psoriasis: a systematic review of incidence and prevalence. Journal of Investigative Dermatology, 133(2), 377-385.
Paroutoglou, K., Papadavid, E., Christodoulatos, G. S., & Dalamaga, M. (2020). Deciphering the association between psoriasis and obesity: current evidence and treatment considerations. Current obesity reports, 9, 165-178.
Pascoe, V. L., & Kimball, A. B. (2015). Seasonal variation of acne and psoriasis: a 3-year study using the Physician Global Assessment severity scale. Journal of the American Academy of Dermatology, 73(3), 523-525.
Pathirana, D., Ormerod, A., Saiag, P., Smith, C., Spuls, P., Nast, A., . . . Chimenti, S. (2009). European S3-guidelines on the systemic treatment of psoriasis vulgaris. Journal of the European Academy of Dermatology and Venereology, 23(SUPPL. 2), 5-70.
Pickett, K., Frampton, G., & Loveman, E. (2016). Education to improve quality of life of people with chronic inflammatory skin conditions: a systematic review of the evidence. British Journal of Dermatology, 174(6), 1228-1241.
Poikolainen, K., Reunala, T., Karvonen, J., Lauharanta, J., & Kärkkäinen, P. (1990). Alcohol intake: a risk factor for psoriasis in young and middle aged men? British Medical Journal, 300(6727), 780-783.
Queiro, R., Tejon, P., Alonso, S., & Coto, P. (2014). Age at disease onset: a key factor for understanding psoriatic disease. Rheumatology, 53(7), 1178-1185.
Rachakonda, T. D., Schupp, C. W., & Armstrong, A. W. (2014). Psoriasis prevalence among adults in the United States. Journal of the American Academy of Dermatology, 70(3), 512-516.
Regidor, E., Barrio, G., de la Fuente, L., Domingo, A., Rodriguez, C., & Alonso, J. (1999). Association between educational level and health related quality of life in Spanish adults. Journal of Epidemiology & Community Health, 53(2), 75-82.
Remröd, C., Sjöström, K., & Svensson, Å. (2013). Psychological differences between early‐and late‐onset psoriasis: a study of personality traits, anxiety and depression in psoriasis. British Journal of Dermatology, 169(2), 344-350.
Robinson, A., Kardos, M., & Kimball, A. B. (2012). Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology, 66(3), 369-375.
Salihbegovic, E. M., Hadzigrahic, N., Suljagic, E., Kurtalic, N., Hadzic, J., Zejcirovic, A., . . . Handanagic, A. (2015). Psoriasis and dyslipidemia. Materia Socio-Medica, 27(1), 15.
Sampogna, F., Chren, M., Melchi, C., Pasquini, P., Tabolli, S., Abeni, D., & Group, I. M. P. R. o. V. E. S. (2006). Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. British Journal of Dermatology, 154(2), 325-331.
Sampogna, F., Tabolli, S., & Abeni, D. (2012). Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta dermato-venereologica, 92(3).
Sanchez‐Carazo, J. L., López‐Estebaranz, J. L., & Guisado, C. (2014). Comorbidities and health‐related quality of life in Spanish patients with moderate to severe psoriasis: a cross‐sectional study (Arizona study). The Journal of dermatology, 41(8), 673-678.
Sendrasoa, F. A., Razanakoto, N. H., Ratovonjanahary, V., Raharolahy, O., Ranaivo, I. M., Andrianarison, M., . . . Ramarozatovo, L. S. (2020). Quality of life in patients with psoriasis seen in the Department of Dermatology, Antananarivo, Madagascar. BioMed Research International, 2020.
Setty, A. R., Curhan, G., & Choi, H. K. (2007). Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Archives of internal medicine, 167(15), 1670-1675.
Shah, S. K., Arthur, A., Yang, Y.-C., Stevens, S., & Alexis, A. F. (2011). A retrospective study to investigate racial and ethnic variations in the treatment of psoriasis with etanercept. Journal of drugs in dermatology: JDD, 10(8), 866-872.
Shao, C. (1987). Distribution of psoriasis in China: a nationwide screening. Pro Chin Acad Med Sci Beijing Union Med Coll, 2, 59-65.
Snast, I., Reiter, O., Atzmony, L., Leshem, Y., Hodak, E., Mimouni, D., & Pavlovsky, L. (2018). Psychological stress and psoriasis: a systematic review and meta‐analysis. British Journal of Dermatology, 178(5), 1044-1055.
Steinke, S. I., Peitsch, W. K., Ludwig, A., & Goebeler, M. (2013). Cost-of-illness in psoriasis: comparing inpatient and outpatient therapy. PLoS One, 8(10), e78152.
WHO. (2016). Global report on Psoriasis. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/204417/9789241565189_eng.pdf.psoriasis?sequence=1
Yin, X., Low, H. Q., Wang, L., Li, Y., Ellinghaus, E., Han, J., . . . Shen, C. (2015). Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nature communications, 6(1), 6916.
Zhang, M., Hong, L., Zhang, T., Lin, Y., Zheng, S., Zhou, X., . . . Zhong, J. (2016). Illness perceptions and stress: mediators between disease severity and psychological well-being and quality of life among patients with Crohn’s disease. Patient preference and adherence, 10, 2387.
Zill, J., Christalle, E., Tillenburg, N., Mrowietz, U., Augustin, M., Härter, M., & Dirmaier, J. (2019). Effects of psychosocial interventions on patient‐reported outcomes in patients with psoriasis: a systematic review and meta‐analysis. British Journal of Dermatology, 181(5), 939-945.
Abuarij, M., & Al Qtwani, A. (2023). Efficacy of Oral Isotretinoin in Combination with Desloratadine in the Treatment of Acne Vulgaris at Al-Thawrah General Hospital, Sana’a, Yemen . Journal of 21 September University for Medical and Applied Sciences, 2(1), 17-30. https://doi.org/10.65693/masj.2023.v2i1.23
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mutaia Abuarij، Emad Al-shameri (المؤلف)
This work is licensed under a Creative Commons Attribution 4.0 International License.
